SAFETY AND EFFICACY OF OUTPATIENT ROBOTIC RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE 2 NON-SEMINOMATOUS GERM CELL TUMOR PATIENTS WITH/ WITHOUT NEOADJUVANT CHEMOTHERAPY

被引：0
|
作者：
Mehrdad, Alemozaffar [1 ]
Jennifer, Lee [1 ]
机构：
[1] Kaiser Permanente Med Ctr, Los Angeles, CA USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2025年 / 43卷 / 03期
关键词：
D O I：
10.1016/j.urolonc.2024.12.089
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
86
引用
收藏
页数：1
相关论文
共 50 条
  • [41] RATES OF TERATOMA AT POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION BY INDUCTION CHEMOTHERAPY REGIMEN FOR GOOD RISK NON-SEMINOMATOUS GERM CELL TUMORS
    Kundu, Shilajit
    Carver, Brett
    Bajorin, Dean
    Motzer, Robert
    Bosl, George
    Feldman, Darren
    Sheinfeld, Joel
    JOURNAL OF UROLOGY, 2011, 185 (04): : E334 - E334
  • [42] Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour, a multicenter retrospective cohort study
    Antonelli, L.
    Heidenreich, A.
    Bagrodia, A.
    Branger, N.
    Cazzaniga, W.
    Clinton, T. N.
    Daneshmand, S.
    Djaladat, H.
    Eggener, S.
    Hamilton, R. J.
    Ho, M.
    Sexton, W. J.
    Nazzani, S.
    Nicol, D.
    Nicolai, N.
    Olson, K.
    Paffenholz, P.
    Porter, J.
    Singla, N.
    Stroup, S. P.
    Tachibana, I
    Terbuch, A.
    Cary, C.
    Fankhauser, C. D.
    EUROPEAN UROLOGY, 2024, 85 : S722 - S723
  • [43] NUMBER OF LYMPH NODES RESECTED AT PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION AND CANCER-SPECIFIC SURVIVAL FOR NON-SEMINOMATOUS GERM CELL TUMOR OF THE TESTICLE
    Large, Michael C.
    Huo, Dezheng
    Eggener, Scott E.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 326 - 326
  • [44] How to do an open midline extraperitoneal bilateral retroperitoneal lymph node dissection for non-seminomatous germ cell tumour
    Parkin, Cameron James
    Sharma, Aditya
    Winter, Matthew
    ANZ JOURNAL OF SURGERY, 2023, 93 (1-2) : 337 - 338
  • [45] Improved clinical outcome for men with fibrosis at post-chemotherapy retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumors
    Carver, Brett S.
    Stasi, Jason
    Bajorin, Dean
    Motzer, Robert J.
    Bosl, George J.
    Sheinfeld, Joel
    JOURNAL OF UROLOGY, 2007, 177 (04): : 330 - 330
  • [46] IMPACT OF FERTILITY AFTER PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) FOR PATIENTS WITH NON-SEMINOMATOUS GERM CELLTUMORS (NSGCT)
    Bey, Aaron L.
    Beck, Stephen D. W.
    Bihrle, Richard
    Foster, Richard
    JOURNAL OF UROLOGY, 2009, 181 (04): : 199 - 199
  • [47] Unilateral Post-Chemotherapy Robot-Assisted Retroperitoneal Lymph Node Dissection for Stage II Non-Seminomatous Germ Cell Tumors: Sexual and Reproductive Outcomes
    Tufano, Antonio
    Cilio, Simone
    Spena, Gianluca
    Izzo, Alessandro
    Castaldo, Luigi
    Grimaldi, Giovanni
    Muscariello, Raffaele
    Franzese, Dario
    Quarto, Giuseppe
    Autorino, Riccardo
    Passaro, Francesco
    Perdona, Sisto
    CANCERS, 2024, 16 (12)
  • [48] DECLINING RATES OF RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE I NON-SEMINOMATOUS GERM CELL TUMORS: RESULTS FROM THE NATIONAL CANCER DATABASE
    Haseebuddin, Mohammed
    Handorf, Elizabeth
    Kutikov, Alexander
    Wainganker, Nikhil
    Wong, Yu-Ning
    Plimack, Elizabeth
    Uzzo, Robert
    Smaldone, Marc
    JOURNAL OF UROLOGY, 2015, 193 (04): : E983 - E983
  • [49] NOVEL PREDICTORS OF BENIGN PATHOLOGY IN STAGE IA OR IB PATIENTS WITH NON-SEMINOMATOUS TESTICULAR GERM CELL MALIGNANCY UNDERGOING PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION
    Adibi, Mehrad
    Cost, Nicholas
    Lubahn, Jessica
    Romman, Adam
    Margulis, Vitaly
    JOURNAL OF UROLOGY, 2012, 187 (04): : E374 - E374
  • [50] NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - MORPHOLOGY OF RETROPERITONEAL LYMPH-NODE METASTASES AFTER CHEMOTHERAPY
    SUURMEIJER, AJH
    OOSTERHUIS, JW
    SLEIJFER, DT
    KOOPS, HS
    FLEUREN, GJ
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06): : 727 - 734
12345